Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Environmentalists allege unsafe PCB levels in omega-3s

This article was originally published in The Tan Sheet

Executive Summary

A March 2 lawsuit filed in California state court alleges dietary supplements with omega-3 fatty acids have "undisclosed and unnecessarily high levels of contamination with polychlorinated biphenyl compounds." Environmental advocates and the Mateel Environmental Justice Foundation name as defendants: CVS Pharmacy Inc., General Nutrition Corp., Now Health Group Inc., Omega Protein Inc., Pharmavite LLC, Rite Aid Corp., Solgar, Inc. and TwinLab Corp. The lawsuit alleges the supplements have PCB levels above the "safe harbor" limit set for human consumption under California's Proposition 65, which requires warnings about such exposures on product labels. The Council for Responsible Nutrition says the levels of PCBs found in the majority of the products do not appear to exceed the Prop 65 limit of 90 ng per day

You may also be interested in...



Fish Oil Firms Float Toxicology Work, Plot Media Blitz To Fight PCB Suit

Fish oil supplement manufacturers will rely on science and strategic public relations to counter a California lawsuit alleging high levels of undisclosed contaminants in their products

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that of rivals Medicenna were presented at the AACR, suggesting there’s life in the modality yet.

Swisse Supplements Take Bigger Slice Of Chinese Market

Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel